The Patent Finder

Tumor Necrosis Factor (TNF) Superfamily Receptor Igm Antibodies and Uses Thereof

Igm Biosciences, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/US2016/014153, filed Jan 20, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,938,347Tumor Necrosis Factor (TNF) Superfamily Receptor Igm Antibodies and Uses Thereof
In force
 · High confidence
Igm Biosciences, Inc.In force
High confidence
US 10,689,449Multimeric Death Domain-Containing RECEPTOR-5 (DR5) Antibodies and Uses Thereof
In force
 · High confidence
Igm Biosciences, Inc.In force
High confidence
US 11,578,131Polynucleotides Encoding Death Domain-Containing RECEPTOR-5 (DR5) Binding Molecules
In force
 · High confidence
Igm Biosciences, Inc.In force
High confidence
Application 18/055,340Tumor Necrosis Factor (TNF) Superfamily Receptor Igm Antibodies and Uses Thereof
Abandoned
Abandoned Feb 27, 2025
Igm Biosciences, Inc.AbandonedAbandoned Feb 27, 2025
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Igm Biosciences, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited